Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析

◆英語タイトル:Syndax Pharmaceuticals Inc (SNDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137805FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the treatment of advanced hormone receptor positive and human epidermal growth factor receptor 2 negative breast cancer. Its product candidate is also used for the treatment of non-small cell lung cancer and melanoma, ovarian cancer and other indications. Syndax also develops SNDX-6352, a monoclonal antibody that targets the CSF-1 receptor. The company operates through its offices in Waltham and New York City, the US. Syndax is headquartered in Waltham, Massachusetts, the US.

Syndax Pharmaceuticals Inc Key Recent Developments

Mar 08,2021: Syndax Pharmaceuticals reports fourth quarter 2020 financial results and provides clinical and business update
Mar 08,2021: Syndax Pharmaceuticals announces reports Q4 results
Dec 18,2020: Syndax Pharmaceuticals to be added to the NASDAQ Biotechnology Index
Nov 02,2020: Syndax Pharmaceuticals reports third quarter 2020 financial results and provides clinical and business update
Aug 06,2020: Syndax Pharmaceuticals reports second quarter 2020 financial results and provides clinical and business update

This comprehensive SWOT profile of Syndax Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Syndax Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Syndax Pharmaceuticals Inc – Key Information
Syndax Pharmaceuticals Inc – Overview
Syndax Pharmaceuticals Inc – Key Employees
Syndax Pharmaceuticals Inc – Key Employee Biographies
Syndax Pharmaceuticals Inc – Key Operational Heads
Syndax Pharmaceuticals Inc – Major Products and Services
Syndax Pharmaceuticals Inc – History
Syndax Pharmaceuticals Inc – Company Statement
Syndax Pharmaceuticals Inc – Locations And Subsidiaries
Syndax Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Syndax Pharmaceuticals Inc – Business Description
Syndax Pharmaceuticals Inc – Corporate Strategy
Syndax Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Syndax Pharmaceuticals Inc – Strengths
Syndax Pharmaceuticals Inc – Weaknesses
Syndax Pharmaceuticals Inc – Opportunities
Syndax Pharmaceuticals Inc – Threats
Syndax Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Syndax Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Syndax Pharmaceuticals Inc, Key Information
Syndax Pharmaceuticals Inc, Key Ratios
Syndax Pharmaceuticals Inc, Share Data
Syndax Pharmaceuticals Inc, Major Products and Services
Syndax Pharmaceuticals Inc, History
Syndax Pharmaceuticals Inc, Key Employees
Syndax Pharmaceuticals Inc, Key Employee Biographies
Syndax Pharmaceuticals Inc, Key Operational Heads
Syndax Pharmaceuticals Inc, Other Locations
Syndax Pharmaceuticals Inc, Subsidiaries
Syndax Pharmaceuticals Inc, Key Competitors
Syndax Pharmaceuticals Inc, SWOT Analysis
Syndax Pharmaceuticals Inc, Ratios based on current share price
Syndax Pharmaceuticals Inc, Annual Ratios
Syndax Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gilead Sciences Inc (GILD):医療機器:M&Aディール及び事業提携情報
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency …
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務情報
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines for heart diseases using stem cell-derived, patient-specific cardiac disease models. It also devel …
  • GAIL (India) Ltd (GAIL):企業の財務・戦略的SWOT分析
    GAIL (India) Ltd (GAIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Deep Down Inc (DPDW):企業の財務・戦略的SWOT分析
    Summary Deep Down Inc (Deep Down) is a subsea oilfield services company that offers exploration and production support products and services. The company provides products such as active heave compensator, asset wellness, bend limiters, bend stiffener latcher, buoyancy modules, carousels, dynamic po …
  • Zincore Metals Inc:企業の戦略・SWOT・財務分析
    Zincore Metals Inc - Strategy, SWOT and Corporate Finance Report Summary Zincore Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Taejoon Pharm Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taejoon Pharm Co Ltd (Taejoon) is a pharmaceutical company that markets ophthalmic agents and other drugs. The company offers injections, powders, eye drops, spray, syrups, tablets, soft capsules, liquids for external use, and hard capsules. Its powder products comprise coolprep powder, taej …
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sandvik AB:企業の戦略・SWOT・財務分析
    Sandvik AB - Strategy, SWOT and Corporate Finance Report Summary Sandvik AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Centrexion Therapeutics Corp (CNTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • Maharashtra State Power Generation Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Maharashtra State Power Generation Co., Ltd. (Mahagenco) is a state government-owned electricity company. The company generates and supplies electricity across the state of Maharashtra, India. Mahagenco owns and operates generation facilities, and uses diverse fuel sources such as thermal, g …
  • NextEra Energy Resources LLC:電力:M&Aディール及び事業提携情報
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …
  • A.P. Eagers Limited:戦略・SWOT・企業財務分析
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Saje Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Saje Pharma LLC (Saje Pharma) is a biopharmaceutical company that develops new therapeutic agents for rare and common diseases with unmet medical needs. The company’s lead product candidate includes SPL-334, developed for various indications such as idiopathic pulmonary fibrosis, asthma, inf …
  • Penn Virginia Corporation (PVAC)-石油・ガス分野:企業M&A・提携分析
    Summary Penn Virginia Corporation (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company carries out its operations in various domestic onshore regions of the US, primarily in the Eagle Ford Shale …
  • Nektar Therapeutics (NKTR):企業の財務・戦略的SWOT分析
    Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Inpex Corp (1605):石油・ガス:M&Aディール及び事業提携情報
    Summary Inpex Corp (Inpex) is an integrated energy company. It explores for, develops and produces oil and natural gas from its assets in domestic and international regions. The company markets crude oil, condensate, natural gas, and LNG. Inpex has working interest in various upstream projects in Eu …
  • Kuwait Investment Authority:電力:M&Aディール及び事業提携情報
    Summary The Kuwait Investment Authority (KIA) is an asset management company. It offers fund management and investment management services. The company is responsible for the management and administration of the General Reserve Fund (GRF), apart from the assets of the Future Generations Fund (FGF). …
  • CPFL Energia SA:発電所・企業SWOT分析
    CPFL Energia SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Esso (Thailand) PCL (ESSO):企業の財務・戦略的SWOT分析
    Esso (Thailand) PCL (ESSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆